X
02Oct

Financial Daily Dose 10.2.2019 | Top Story: Johnson & Johnson Pays Out $20 Million to Avoid First Opioid Trial

Johnson & Johnson doled out $20 million to two Ohio counties rather than go through with its first federal opioid-related trial. The money is rather small potatoes for J&J, but it marks the “first time . . . the world’s largest maker of healthcare...
By: Robins Kaplan LLP
Source Url: https://www.jdsupra.com/legalnews/financial-daily-dose-10-2-2019-top-36979/

Related

Federal Court Rejects Assembly Bill 51

Assembly Bill 51 (“AB 51”) prohibits employers from requiring employees to execute arbitration agr...

Read More >

[Video] This Week in FCPA-Episode 173, week ending September 26, 2019 – the Franchise Record edition

As Tom celebrates the Astros franchise record of 104 wins (to-date) and Jay continues to avoid talki...

Read More >

FTC’s 2020 Adjustments to HSR Filing Thresholds

The Federal Trade Commission (“FTC”) announced its annual adjustment for notification thresholds f...

Read More >

Private Equity in the United Kingdom - 2020 Edition

Dechert partnered with Getting the Deal Through and Law Business Research on their annual Market Int...

Read More >

Financial Statement Requirements in US Securities Offerings: What You Need to Know - 2020 Edition

The most frequently asked question at all-hands meetings for a securities offering is “What financi...

Read More >

First Circuit Finds That Funds Were Not Liable for Portfolio Company’s Pension Fund Withdrawal Liability

On November 22, 2019, the United States Court of Appeals for the First Circuit held that two separat...

Read More >